Table 5 Treatment-Emergent Adverse Events reported by Two or More Subjects
Adverse Event | Placebo | BUDCA Dose | ||
|---|---|---|---|---|
500 mg/day | 1000 mg/day | 2000 mg/day | ||
Number of Subjects | 12 | 12 | 12 | 14 |
Headache | 5 | 5 | 4 | 3 |
Dizziness | 0 | 2 | 0 | 0 |
Nausea | 1 | 3 | 1 | 0 |
Flatulence | 2 | 0 | 0 | 0 |
Anorexia | 0 | 0 | 3 | 1 |